Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Abstract LB376: Tirzepatide inhibits tumor growth in mice with diet-induced obesity

Michael N. Pollak, Jibin Zeng, Linxuan Huang, Ye Wang, Janane Rahbani, Lawrence Kazak

Cancer Res (2024) 84 (7_Supplement): LB376.

https://doi.org/10.1158/1538-7445.AM2024-LB376

Published: 05 April 2024

View article titled, Abstract LB376: Tirzepatide inhibits tumor growth in mice with diet-induced obesity

Journal Articles

Abstract LB093: Low IGFBP7 expression identifies a subset of breast cancers with favorable prognosis and sensitivity to IGF-1 receptor targeting with ganitumab: Data from I-SPY2 and SCAN-B

Christopher Godina, Michael N. Pollak, Helena Jernström

Cancer Res (2024) 84 (7_Supplement): LB093.

https://doi.org/10.1158/1538-7445.AM2024-LB093

Published: 05 April 2024

View article titled, Abstract LB093: Low IGFBP7 expression identifies a subset of breast cancers with favorable prognosis and sensitivity to IGF-1 receptor targeting with ganitumab: Data from I-SPY2 and SCAN-B

Journal Articles

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission

Kenneth C. Anderson, Lewis C. Cantley, Riccardo Dalla-Favera, Chi Van Dang, Luis A. Diaz, Raymond N. DuBois, Keith T. Flaherty, Philip D. Greenberg, Massimo Loda, Elaine R. Mardis, Elizabeth A. Platz, Michael N. Pollak, Robert D. Schreiber, Lillian L. Siu, Beverly A. Teicher

Cancer Res (2022) 82 (21): 3861–3867.

https://doi.org/10.1158/0008-5472.CAN-22-2453

Published: 02 November 2022

View article titled, The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission

Journal Articles

Abstract CT521: Phase 1b trial of the MNK1/2 inhibitor tomivosertib combined with paclitaxel in patients with metastatic breast cancer

Cristiano Ferrario, John Mackey, Karen Gelmon, Poul HB Sorensen, Htoo Zarni Oo, Gregg B. Morin, Sonia del Rincon, Mehdi Amiri, Premal Patel, Harvey W. Smith, Nahum Sonenberg, Michael N. Pollak

Cancer Res (2022) 82 (12_Supplement): CT521.

https://doi.org/10.1158/1538-7445.AM2022-CT521

Published: 15 June 2022

View article titled, Abstract CT521: Phase 1b trial of the MNK1/2 inhibitor tomivosertib combined with paclitaxel in patients with metastatic breast cancer

Journal Articles

Abstract SY28-03: Extending the paradigm of hormonal dependency of cancer to account for effects of lifestyle on risk and prognosis

Michael N. Pollak

Cancer Res (2019) 79 (13_Supplement): SY28-03.

https://doi.org/10.1158/1538-7445.AM2019-SY28-03

Published: 01 July 2019

View article titled, Abstract SY28-03: Extending the paradigm of hormonal dependency of cancer to account for effects of lifestyle on risk and prognosis

Journal Articles

Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms

Cancer Res (2016) 76 (24): 7160–7167.

https://doi.org/10.1158/0008-5472.CAN-16-1699

Published: 15 December 2016

View article titled, Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms

Includes: Supplementary data

Journal Articles

Abstract CT156: Safety and tolerability of metformin for chemoprevention in Li-Fraumeni syndrome (LFS)

Farzana Lukmanji Walcott, Paul M. Hwang, Ping-yuan Wang, Sharon A. Savage, Phuong Mai, Seth M. Steinberg, Michael N. Pollak, Christina Annunziata, Antonio T. Fojo

Cancer Res (2016) 76 (14_Supplement): CT156.

https://doi.org/10.1158/1538-7445.AM2016-CT156

Published: 15 July 2016

View article titled, Abstract CT156: Safety and tolerability of metformin for chemoprevention in Li-Fraumeni syndrome (LFS)

Journal Articles

A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

Ruth C. Travis, Paul N. Appleby, Richard M. Martin, Jeff M.P. Holly, Demetrius Albanes, Amanda Black, H. Bas Bueno-de-Mesquita, June M. Chan, Chu Chen, Maria-Dolores Chirlaque, Michael B. Cook, Mélanie Deschasaux, Jenny L. Donovan, Luigi Ferrucci, Pilar Galan, Graham G. Giles, Edward L. Giovannucci, Marc J. Gunter, Laurel A. Habel, Freddie C. Hamdy, Kathy J. Helzlsouer, Serge Hercberg, Robert N. Hoover, Joseph A.M.J.L. Janssen, Rudolf Kaaks, Tatsuhiko Kubo, Loic Le Marchand, E. Jeffrey Metter, Kazuya Mikami, Joan K. Morris, David E. Neal, Marian L. Neuhouser, Kotaro Ozasa, Domenico Palli, Elizabeth A. Platz, Michael N. Pollak, Alison J. Price, Monique J. Roobol, Catherine Schaefer, Jeannette M. Schenk, Gianluca Severi, Meir J. Stampfer, Pär Stattin, Akiko Tamakoshi, Catherine M. Tangen, Mathilde Touvier, Nicholas J. Wald, Noel S. Weiss, Regina G. Ziegler, Timothy J. Key, Naomi E. Allen

Cancer Res (2016) 76 (8): 2288–2300.

https://doi.org/10.1158/0008-5472.CAN-15-1551

Published: 14 April 2016

View article titled, A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

Includes: Supplementary data

Journal Articles

Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals

Jonathan N. Hofmann, Brenda M. Birmann, Lauren R. Teras, Ruth M. Pfeiffer, Ye Wang, Demetrius Albanes, Dalsu Baris, Graham A. Colditz, Anneclaire J. De Roos, Graham G. Giles, H. Dean Hosgood, Qing Lan, Ola Landgren, Linda M. Liao, Nathaniel Rothman, Stephanie J. Weinstein, Michael N. Pollak, Marian L. Neuhouser, Mark P. Purdue

Cancer Res (2016) 76 (7): 1935–1941.

https://doi.org/10.1158/0008-5472.CAN-15-2406

Published: 31 March 2016

View article titled, Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals

Includes: Supplementary data

Journal Articles

Abstract 934: A pooled investigation of circulating adiponectin levels and risk of multiple myeloma

Cancer Res (2015) 75 (15_Supplement): 934.

https://doi.org/10.1158/1538-7445.AM2015-934

Published: 01 August 2015

View article titled, Abstract 934: A pooled investigation of circulating adiponectin levels and risk of multiple myeloma

Journal Articles

Abstract 29: Design of a phase I chemoprevention study of metformin and Li-Fraumeni syndrome (LFS)

Farzana L. Walcott, Paul M. Hwang, Ping-yuan Wang, Sharon A. Savage, Phuong Mai, Seth M. Steinberg, Michael N. Pollak, Philip A. Dennis, Antonio Tito Fojo

Cancer Res (2014) 74 (23_Supplement): 29.

https://doi.org/10.1158/1538-7445.CANSUSC14-29

Published: 12 December 2014

View article titled, Abstract 29: Design of a phase I chemoprevention study of metformin and Li-Fraumeni syndrome (LFS)

Journal Articles

Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism

Sarah-Maria Fendt, Eric L. Bell, Mark A. Keibler, Shawn M. Davidson, Gregory J. Wirth, Brian Fiske, Jared R. Mayers, Matthias Schwab, Gary Bellinger, Alfredo Csibi, Akash Patnaik, Marie Jose Blouin, Lewis C. Cantley, Leonard Guarente, John Blenis, Michael N. Pollak, Aria F. Olumi, Matthew G. Vander Heiden, Gregory Stephanopoulos

Cancer Res (2013) 73 (14): 4429–4438.

https://doi.org/10.1158/0008-5472.CAN-13-0080

Published: 15 July 2013

View article titled, Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism

Includes: Supplementary data

Journal Articles

Abstract 4615: The hyperinsulinemia caused by PI3K inhibitors attenuates their antineoplastic efficacy, but can be minimized by co-administration of metformin.

Marie-José Blouin, Elena Birman, Yunhua Zhao, Mahvash Zakikhani, Michael N. Pollak

Cancer Res (2013) 73 (8_Supplement): 4615.

https://doi.org/10.1158/1538-7445.AM2013-4615

Published: 15 April 2013

View article titled, Abstract 4615: The hyperinsulinemia caused by PI3K inhibitors attenuates their antineoplastic efficacy, but can be minimized by co-administration of metformin.

Journal Articles

Abstract LB-28: The IGF/insulin signaling axis TMPRSS2:ERG and prostate cancer survival.

Thomas U. Ahearn, Andreas Pettersson, Edward C. Stack, Jing Ma, Travis Gerke, Allison Meisner, Michael N. Pollak, Stephen Finn, Meir J. Stampfer, Massimo Loda, Edward L. Giovannucci, Lorelei A. Mucci

Cancer Res (2013) 73 (8_Supplement): LB-28.

https://doi.org/10.1158/1538-7445.AM2013-LB-28

Published: 15 April 2013

View article titled, Abstract LB-28: The IGF/insulin signaling axis TMPRSS2:ERG and prostate cancer survival.

Journal Articles

Carbon Source and Myc Expression Influence the Antiproliferative Actions of Metformin

Shiva Javeshghani, Mahvash Zakikhani, Shane Austin, Miguel Bazile, Marie-José Blouin, Ivan Topisirovic, Julie St-Pierre, Michael N. Pollak

Cancer Res (2012) 72 (23): 6257–6267.

https://doi.org/10.1158/0008-5472.CAN-12-2907

Published: 29 November 2012

View article titled, Carbon Source and Myc Expression Influence the Antiproliferative Actions of Metformin

Journal Articles

Abstract LB-169: Metformin reduces somatic cell mutation rate by inhibiting mitochondrial ROS production: relevance to cancer prevention

Michael N. Pollak, carolyn Algire, Gerardo Ferbeyre

Cancer Res (2012) 72 (8_Supplement): LB-169.

https://doi.org/10.1158/1538-7445.AM2012-LB-169

Published: 15 April 2012

View article titled, Abstract LB-169: Metformin reduces somatic cell mutation rate by inhibiting mitochondrial ROS production: relevance to cancer prevention

Journal Articles

Abstract 2300: Insulin receptor kinase inhibition is better tolerated than hypoinsulinemia and more effective than metformin in treating breast cancer

Carly Dool, Haider Mashhedi, Mahvash Zakikhani, Stephanie David, Yunhua Zhao, Elena Birman, Joan M. Carboni, Marco Gottardis, Marie-Jose Blouin, Michael N. Pollak

Cancer Res (2011) 71 (8_Supplement): 2300.

https://doi.org/10.1158/1538-7445.AM2011-2300

Published: 15 April 2011

View article titled, Abstract 2300: Insulin receptor kinase inhibition is better tolerated than hypoinsulinemia and more effective than metformin in treating breast cancer

Journal Articles

Synthetic Lethality Screens Reveal RPS6 and MST1R as Modifiers of Insulin-like Growth Factor-1 Receptor Inhibitor Activity in Childhood Sarcomas

Jenny C. Potratz, Darren N. Saunders, Daniel H. Wai, Tony L. Ng, Steven E. McKinney, Joan M. Carboni, Marco M. Gottardis, Timothy J. Triche, Heribert Jürgens, Michael N. Pollak, Samuel A. Aparicio, Poul H.B. Sorensen

Cancer Res (2010) 70 (21): 8770–8781.

https://doi.org/10.1158/0008-5472.CAN-10-1093

Published: 31 October 2010

View article titled, Synthetic Lethality Screens Reveal RPS6 and MST1R as Modifiers of Insulin-like Growth Factor-1 Receptor Inhibitor Activity in Childhood Sarcomas

Includes: Supplementary data

Journal Articles

Abstract 4830: Insulin-like growth factors and kidney cancer risk in men

Jacqueline M. Major, Michael N. Pollak, Kirk Snyder, Jarmo Virtamo, Demetrius Albanes

Cancer Res (2010) 70 (8_Supplement): 4830.

https://doi.org/10.1158/1538-7445.AM10-4830

Published: 15 April 2010

View article titled, Abstract 4830: Insulin-like growth factors and kidney cancer risk in men

Journal Articles

Abstract 2795: Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Jason B. Douglas, Debra T. Silverman, Michael N. Pollak, Yuzhen Tao, Amr S. Soliman, Rachael Z. Stolzenberg-Solomon

Cancer Res (2010) 70 (8_Supplement): 2795.

https://doi.org/10.1158/1538-7445.AM10-2795

Published: 15 April 2010

View article titled, Abstract 2795: Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

NARROW

Abstract LB376: Tirzepatide inhibits tumor growth in mice with diet-induced obesity

Abstract LB093: Low IGFBP7 expression identifies a subset of breast cancers with favorable prognosis and sensitivity to IGF-1 receptor targeting with ganitumab: Data from I-SPY2 and SCAN-B

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission

Abstract CT521: Phase 1b trial of the MNK1/2 inhibitor tomivosertib combined with paclitaxel in patients with metastatic breast cancer

Abstract SY28-03: Extending the paradigm of hormonal dependency of cancer to account for effects of lifestyle on risk and prognosis

Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms

Abstract CT156: Safety and tolerability of metformin for chemoprevention in Li-Fraumeni syndrome (LFS)

A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals

Abstract 934: A pooled investigation of circulating adiponectin levels and risk of multiple myeloma

Abstract 29: Design of a phase I chemoprevention study of metformin and Li-Fraumeni syndrome (LFS)

Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism

Abstract 4615: The hyperinsulinemia caused by PI3K inhibitors attenuates their antineoplastic efficacy, but can be minimized by co-administration of metformin.

Abstract LB-28: The IGF/insulin signaling axis TMPRSS2:ERG and prostate cancer survival.

Carbon Source and Myc Expression Influence the Antiproliferative Actions of Metformin

Abstract LB-169: Metformin reduces somatic cell mutation rate by inhibiting mitochondrial ROS production: relevance to cancer prevention

Abstract 2300: Insulin receptor kinase inhibition is better tolerated than hypoinsulinemia and more effective than metformin in treating breast cancer

Synthetic Lethality Screens Reveal RPS6 and MST1R as Modifiers of Insulin-like Growth Factor-1 Receptor Inhibitor Activity in Childhood Sarcomas

Abstract 4830: Insulin-like growth factors and kidney cancer risk in men

Abstract 2795: Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only